Anumana Acquires NeuTrace to Build Electrophysiology AI Platform

November 7, 2022

Anumana, an AI-driven health technology company and portfolio company of nference and Mayo Clinic Platform, has acquired NeuTrace and its EP Data Biome platform along with a pipeline of AI-enabled electrophysiology (EP) applications. nference also obtained rights to the Data Biome platform for non-cardiovascular uses, positioning Anumana to expand its in‑procedure AI capabilities and product development across cardiac electrophysiology.

Buyers
Anumana, nference
Targets
NeuTrace
Industry
Medical Devices
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.